Ketamine for PTSD

Post-traumatic stress disorder changes the architecture of the brain. It rewires the neural circuits responsible for fear, memory, and emotional regulation, leaving survivors trapped in a state of hypervigilance long after the danger has passed. For many people with PTSD, standard treatments such as psychotherapy and antidepressants bring partial relief at best. The intrusive memories persist. The nightmares continue. The body remains on alert.

Ketamine therapy offers a different approach, one that works not just on symptoms but on the underlying neural circuitry that perpetuates PTSD. By rapidly promoting neuroplasticity and modulating the brain's fear response system, ketamine has the potential to help where conventional treatments have reached their limits.

Understanding PTSD

Post-traumatic stress disorder develops after exposure to a traumatic event, whether experienced directly, witnessed, or learned about happening to someone close. While trauma responses are initially normal and adaptive, PTSD occurs when the brain fails to properly process and integrate the traumatic experience, keeping the individual stuck in a heightened state of threat response.

Symptom Clusters

PTSD is characterized by four symptom clusters:

1. Intrusion symptoms: Flashbacks, nightmares, intrusive memories, and intense distress when exposed to reminders of the trauma
2. Avoidance: Deliberate avoidance of thoughts, feelings, places, people, or situations associated with the trauma
3. Negative alterations in cognition and mood: Persistent negative beliefs about oneself or the world, distorted blame, diminished interest in activities, emotional numbness, and inability to experience positive emotions
4. Hyperarousal: Hypervigilance, exaggerated startle response, difficulty sleeping, irritability, difficulty concentrating, and reckless or self-destructive behavior

Complex PTSD

Complex PTSD (C-PTSD) results from prolonged or repeated trauma, such as childhood abuse, domestic violence, human trafficking, or prolonged combat exposure. In addition to the standard PTSD symptoms, C-PTSD involves:

• Severe difficulties with emotional regulation
• Negative self-concept (persistent feelings of worthlessness, shame, or guilt)
• Disrupted relationships and difficulty trusting others

C-PTSD is often more challenging to treat than single-incident PTSD and may respond less completely to standard trauma therapies alone.

The Neuroscience of PTSD

PTSD involves measurable changes in brain structure and function:⁹

• Amygdala hyperactivity: The brain's threat detection center becomes overactive, triggering fear responses to non-threatening stimuli
• Prefrontal cortex hypoactivity: The brain region responsible for rational evaluation of threats and emotional regulation becomes underactive, unable to adequately "brake" amygdala responses
• Hippocampal changes: The hippocampus, which normally contextualizes memories in time and place, may shrink and function less effectively, contributing to the "timeless" quality of traumatic memories
• Fear extinction failure: The brain's normal process of learning that previously threatening stimuli are now safe is impaired in PTSD

These neural changes explain why trauma survivors cannot simply "get over it." PTSD is a physiological condition involving altered brain circuitry, and effective treatment must address these biological changes.

How Ketamine Treats PTSD

Restoring Fear Extinction

One of the most relevant mechanisms of ketamine for PTSD involves fear extinction, the brain's process of learning that a previously threatening stimulus is no longer dangerous. This process is critical for trauma recovery and is the basis of exposure-based therapies like prolonged exposure (PE) and cognitive processing therapy (CPT).⁴

In PTSD, fear extinction is impaired. The brain continues to respond to trauma reminders as though the danger is present. Ketamine's effects on the glutamate system and NMDA receptors directly influence the neural circuits responsible for fear learning and extinction:⁵

• Enhanced glutamate signaling in the prefrontal cortex strengthens the brain's ability to override fear responses
• BDNF-driven neuroplasticity creates new synaptic connections that support the formation of new, non-threatening associations
• Amygdala modulation may temporarily reduce the intensity of fear responses, providing a window for therapeutic processing

The Neuroplasticity Window

Research suggests that ketamine creates a "critical period" of enhanced neuroplasticity in the 24-48 hours following treatment.⁸ During this window, the brain is more receptive to forming new connections and consolidating new learning. This has led to the development of ketamine-assisted psychotherapy protocols that strategically time therapy sessions to coincide with this period of enhanced plasticity.

Memory Reconsolidation

When memories are recalled, they enter a labile state where they can be modified before being re-stored, a process called reconsolidation. Some researchers theorize that ketamine may facilitate memory reconsolidation, allowing traumatic memories to be reprocessed with reduced emotional intensity and re-stored in a less distressing form.⁴

Research Evidence

The Feder 2014 Landmark Trial

The groundbreaking study of ketamine for PTSD was conducted by Feder and colleagues at Columbia University and published in JAMA Psychiatry. This randomized, double-blind, crossover study compared a single IV ketamine infusion (0.5 mg/kg) to an active placebo (midazolam) in 41 patients with chronic PTSD.¹

Key findings:

• Ketamine produced significant reduction in PTSD symptoms compared to midazolam within 24 hours
• The Impact of Event Scale-Revised (IES-R) scores dropped substantially in the ketamine group
• Effects were evident across all PTSD symptom clusters: intrusion, avoidance, and hyperarousal
• Improvement was maintained for a median of 7 days after a single infusion
• Comorbid depressive symptoms also improved significantly
• Side effects were transient and consistent with expected ketamine effects

This study established that ketamine could rapidly reduce PTSD symptoms, providing crucial evidence for this treatment approach.

The Feder 2021 Repeated Infusion Study

Building on their earlier work, Feder and colleagues conducted a larger randomized controlled trial examining whether repeated ketamine infusions could produce more sustained PTSD symptom relief.²

Study design and results:

• 30 participants with chronic PTSD received either 6 ketamine infusions (0.5 mg/kg) or 6 midazolam infusions over 2 weeks
• 67% of ketamine recipients showed clinically meaningful improvement in PTSD symptoms compared to 20% with midazolam
• Improvements were sustained through a 2-week follow-up period after the final infusion
• Both PTSD and depression symptoms improved significantly
• The repeated infusion protocol produced more robust and sustained effects than a single infusion

This study demonstrated that the standard 6-infusion ketamine protocol, widely used for depression, is also effective for PTSD.

Ketamine-Assisted Psychotherapy Research

An emerging and particularly exciting area is the combination of ketamine with psychotherapy. Preliminary clinical reports suggest that ketamine may enhance the effectiveness of trauma-focused therapies:⁶

• Prolonged exposure therapy combined with ketamine may accelerate habituation to trauma memories
• EMDR (Eye Movement Desensitization and Reprocessing) may work more efficiently during the post-ketamine neuroplasticity window
• Cognitive processing therapy may benefit from the cognitive flexibility that ketamine promotes
• Some providers conduct therapy during low-dose ketamine administration, reporting that patients can engage with traumatic material with reduced distress

Peritraumatic Ketamine

An intriguing line of research has examined whether ketamine administered soon after a traumatic event might prevent PTSD from developing. Ketamine is commonly used as an anesthetic in emergency and battlefield medicine, and retrospective studies have shown that trauma patients who received ketamine during emergency treatment may have lower rates of subsequent PTSD.⁷

However, findings are mixed, and prospective studies are needed to determine whether peritraumatic ketamine is truly protective.

Treatment Options for PTSD

IV Ketamine Infusions

The most studied approach for PTSD follows the standard depression protocol:

• Dose: 0.5 mg/kg infused over 40 minutes
• Initial series: 6 infusions over 2-3 weeks
• Maintenance: Individualized, typically every 3-6 weeks
• PTSD-specific considerations: Some providers offer slightly modified protocols, such as slower infusion rates for patients who find the dissociative experience triggering

Learn more about IV ketamine infusions

Ketamine-Assisted Psychotherapy (KAP)

For PTSD specifically, the combination of ketamine with psychotherapy is considered by many experts to be the most promising approach:

• Ketamine infusion followed by a therapy session within 24-48 hours
• Some practitioners conduct therapy during sublingual ketamine administration
• The goal is to leverage the neuroplasticity window for enhanced trauma processing
• Requires a therapist experienced in both trauma treatment and ketamine-assisted therapy

Sublingual and Oral Ketamine

Sublingual ketamine may be used as a maintenance treatment between infusion sessions or as a lower-intensity option for patients who find the IV route too overwhelming initially.

What to Expect During Treatment

PTSD-Specific Preparation

Patients with PTSD have unique considerations when preparing for ketamine therapy:

• Discuss trauma history with your provider: Your ketamine provider should understand your trauma type, triggers, and current symptom severity
• Coordinate with your therapist: If you are in ongoing therapy, your therapist and ketamine provider should communicate about treatment planning
• Prepare for the dissociative experience: For trauma survivors, the loss of control associated with dissociation can feel triggering. Pre-treatment education about what to expect and strategies for grounding can be very helpful
• Choose your clinical environment carefully: Some patients prefer eye masks and music to create a contained inner experience; others prefer to keep their eyes open and maintain visual contact with the room
• Have a support person available: While not required, some patients find it comforting to have a trusted person available by phone after treatment

During the Infusion

The dissociative experience during ketamine treatment has a unique relationship with PTSD:

• Some patients report that traumatic memories may surface during the infusion, but with a quality of emotional distance that makes them less overwhelming
• The experience often feels dreamlike, and many patients describe it as therapeutic in itself
• A trained clinician should be present who understands trauma responses and can provide reassurance
• If the experience becomes distressing, the infusion can be slowed or stopped

After Treatment and Integration

Integration, the process of making meaning from the ketamine experience and applying insights to daily life, is particularly important for PTSD patients:

• Journaling about the experience within the first 24 hours
• Scheduling a therapy session within 1-3 days of the infusion to process any material that emerged
• Practicing grounding techniques if dissociative effects linger
• Monitoring PTSD symptoms with standardized measures (your provider may use the PCL-5)

Read our complete guide to ketamine aftercare

Candidate Screening for PTSD Patients

Who May Benefit

Ketamine for PTSD is most commonly considered for:

• Adults with PTSD who have not responded adequately to first-line treatments (SSRIs plus evidence-based psychotherapy)
• Veterans with combat-related PTSD who have exhausted VA treatment options
• Patients with complex PTSD who have had limited response to standard trauma therapies
• Individuals with PTSD and comorbid depression, where the dual benefit of ketamine may be particularly valuable
• Patients in acute crisis with severe PTSD symptoms who need rapid intervention

PTSD-Specific Contraindications

Beyond standard ketamine contraindications:

• Active dissociative disorders: Ketamine's dissociative effects may worsen symptoms of dissociative identity disorder or depersonalization/derealization disorder
• Severe substance use disorders: Active alcohol or drug dependence requires stabilization before ketamine treatment
• Current active psychosis: PTSD can occasionally co-occur with psychotic features, which may be exacerbated by ketamine
• Severe traumatic brain injury: Some evidence suggests caution in patients with significant TBI, though mild TBI is not necessarily a contraindication

Cost and Insurance

Pricing

• IV ketamine infusions: $400-$800 per session; standard series of 6 costs $2,400-$4,800
• Ketamine-assisted psychotherapy: $500-$1,200 per combined session (infusion plus therapy)
• Maintenance infusions: $400-$800 every 3-6 weeks
• Initial evaluation: $150-$350

Coverage and Assistance

• All ketamine treatment for PTSD is off-label, and insurance coverage is rare
• VA coverage: Some VA medical centers may cover ketamine for PTSD through research protocols
• Veterans organizations: Several nonprofits offer grants or fundraising assistance for veterans seeking ketamine therapy
• HSA/FSA accounts: Can typically be used for ketamine treatments
• Many clinics offer payment plans and sliding scale options

See our complete guide to ketamine costs

Finding a Provider

For PTSD patients specifically, look for providers who:

• Have trauma-informed training and experience treating PTSD with ketamine
• Offer ketamine-assisted psychotherapy protocols, not just infusion-only services
• Maintain collaborative care with therapists experienced in EMDR, CPT, or prolonged exposure
• Understand the unique needs of veteran patients (if applicable)
• Provide comprehensive screening that assesses PTSD severity, comorbidities, and trauma history
• Create a trauma-sensitive clinical environment (quiet, calming, with patient control over the experience)

Find a ketamine clinic near you

PTSD is a treatable condition. If you are a veteran in crisis, please call the Veterans Crisis Line: dial 988 then press 1, or text 838255. For non-veterans, call the 988 Suicide and Crisis Lifeline (call or text 988). Help is available right now.